We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.43B
AUM Growth
+$167M
Cap. Flow
+$133M
Cap. Flow %
9.29%
Top 10 Hldgs %
17.69%
Holding
2,260
New
562
Increased
806
Reduced
460
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 18.13%
2 Healthcare 14.4%
3 Financials 11.38%
4 Consumer Discretionary 10.22%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TK icon
1726
Teekay
TK
$981M
$4K ﹤0.01%
+1,080
New +$4.16K
UBX
1727
DELISTED
Unity Biotechnology
UBX
$4K ﹤0.01%
+47
New +$4K
URBN icon
1728
Urban Outfitters
URBN
$6.58B
$4K ﹤0.01%
+165
New +$4.47K
VC icon
1729
Visteon
VC
$2.8B
$4K ﹤0.01%
+76
New +$4.64K
VERI icon
1730
Veritone
VERI
$120M
$4K ﹤0.01%
517
+179
+53% +$1.33K
VNDA icon
1731
Vanda Pharmaceuticals
VNDA
$305M
$4K ﹤0.01%
300
-7,992
-96% -$127K
VTOL icon
1732
Bristow Group
VTOL
$1.35B
$4K ﹤0.01%
+252
New +$4.5K
YARW
1733
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
0
WATT icon
1734
Energous
WATT
$101M
$4K ﹤0.01%
+1
New +$2.92K
WNEB icon
1735
Western New England Bancorp
WNEB
$276M
$4K ﹤0.01%
427
-600
-58% -$5.65K
XERS icon
1736
Xeris Biopharma Holdings
XERS
$1.34B
$4K ﹤0.01%
381
ZG icon
1737
Zillow
ZG
$7.55B
$4K ﹤0.01%
+80
New +$3.14K
FFNW
1738
DELISTED
First Financial Northwest, Inc
FFNW
$4K ﹤0.01%
300
IVAC
1739
DELISTED
Intevac Inc
IVAC
$4K ﹤0.01%
913
-878
-49% -$4.59K
LUMO
1740
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4K ﹤0.01%
264
TAST
1741
DELISTED
Carrols Restaurant Group, Inc.
TAST
$4K ﹤0.01%
442
+237
+116% +$2.18K
BFX
1742
DELISTED
BowFlex Inc.
BFX
$4K ﹤0.01%
1,720
-2,093
-55% -$8.26K
FRGI
1743
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$4K ﹤0.01%
+276
New +$3.68K
INFI
1744
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$4K ﹤0.01%
2,246
SURF
1745
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$4K ﹤0.01%
1,271
-5,472
-81% -$21.8K
CNCE
1746
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$4K ﹤0.01%
+299
New +$3.21K
SPNE
1747
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$4K ﹤0.01%
275
-2,099
-88% -$29.4K
CLVS
1748
DELISTED
Clovis Oncology, Inc.
CLVS
$4K ﹤0.01%
254
+204
+408% +$3.69K
CVET
1749
DELISTED
Covetrus, Inc. Common Stock
CVET
$4K ﹤0.01%
+155
New +$4.47K
NPTN
1750
DELISTED
NEOPHOTONICS CORP
NPTN
$4K ﹤0.01%
846
+416
+97% +$2.19K

Similar funds

Meeder Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Meeder Asset Management held 2,260 positions worth $1.43B, up 13% from $1.27B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Meeder Asset Management deployed $133M of net new capital in Q2 2019, opening 562 new positions and adding to 806 existing holdings. Its largest new stake was US Bancorp: 69,622 shares worth $3.65M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $11.3M trimmed.

  • Meeder Asset Management's largest Q2 2019 buy was US Bancorp: 69,622 shares worth $3.65M.
  • Meeder Asset Management added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $13.3M increase.
  • Meeder Asset Management's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $11.3M.
  • Meeder Asset Management fully exited Euronet Worldwide in Q2 2019, selling an estimated $1.02M.
  • Meeder Asset Management's ten largest holdings make up 18% of its $1.43B portfolio in Q2 2019.
  • Meeder Asset Management opened 562 new positions and closed 207 in Q2 2019.
  • Meeder Asset Management's portfolio value rose 13% quarter-over-quarter to $1.43B.

Based on Meeder Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.